C-Reactive Protein Upregulates Complement-Inhibitory Factors in Endothelial Cells

Circulation

Volumn 109, Issue 7, 2004, Pages 833-836

  Li, Shu Hong ^a   Szmitko, Paul E ^a   Weisel, Richard D ^a   Wang, Chao Hung ^a   Fedak, Paul W M ^a   Li, Ren Ke ^a   Mickle, Donald A G ^a   Verma, Subodh ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Atherosclerosis; Endothelium; Proteins

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CYTOLYSIS; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INFLAMMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAPHENOUS VEIN GRAFT;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; ANTIGENS, CD46; ANTIGENS, CD55; ANTIGENS, CD59; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; RNA, MESSENGER; SAPHENOUS VEIN;

EID: 1342288504     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000117087.27524.0E     Document Type: Article

References (21)

1. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.
2. Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003;107:370-372.
3. Szmitko PE, Wang CH, Weisel RD, et al. New markers of inflammation and endothelial cell activation. Circulation. 2003;108:1917-1923.
4. Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913-919.
5. Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation. 2002;105:1890-1896.
6. Wang CH, Li SH, Weisel RD, et al. C-reactive protein upregulates angiotensin type I receptors in vascular smooth muscle. Circulation. 2003;107:1783-1790.
7. Wolbink GJ, Brouwer MC, Buysmann S, et al. CRP-mediated activation of complement in vivo. J Immunol. 1996;157:473-479.
8. Walport MJ. Complement: first of two parts. N Engl J Med. 2001;344:1058-1066.
9. Niculescu F, Rus H. Complement activation and atherosclerosis. Mol Immunol. 1999;36:949-955.
10. Yasojima K, Schwab C, McGeer EG, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol. 2001;158:1039-1057.
11. Liszewski MK, Fatties TC, Lublin DM, et al. Control of the complement system. Adv Immunol. 1996;61:201-283.
12. Mason JC, Ahmed Z, Mankoff R, et al. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury. Circ Res. 2002;91:696-703.
13. Bhakdi S, Torzewski M, Klouche M, et al. Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol. 1999;19:2348-2354.
14. Berman S, Gewurz H, Mold C. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis. J Immunol. 1986;136:1354-1359.
15. Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology. 1999;42:23-30.
16. Miyagawa S, Shirakura R, Iwata K, et al. Effects of transfected complement regulatory proteins MCP, DAF, MCP/DAF hybrid on complement-mediated swine endothelial cell lysis. Transplantation. 1994;58:834-840.
17. Mason JC, Lidington EA, Yarwood H, et al. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis. Arthritis Rheum. 2001;44:138-150.
18. Mason JC, Yarwood H, Sugars K, et al. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition. Blood. 1999;94:1673-1682.
19. Hattori Y, Matsumura M, Kasai K. Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res. 2003;58:186-195.
20. Yasojima K, Schwab C, McGeer PL. Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001;21:1214-1219.
21. Blake GJ, Ridker PM. C-reactive protein: a surrogate risk marker or mediator of atherothrombosis? Am J Physiol Regul Integr Comp Physiol. 2003;285:R1250-R1252.